{"title":"因产广谱b-内酰胺酶肠杆菌科(ESBL)和/或产碳青霉烯酶(CPE)引起的感染的治疗:头孢他啶-阿维巴坦在比利时治疗武库中的位置?","authors":"S. Milas, M. Hites","doi":"10.30637/2020.19-046","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":341141,"journal":{"name":"Revue Médicale de Bruxelles","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of infections due to Extended Spectrum b-Lactamase Producing Enterobacteriaceae (ESBL) and/or producing Carbapenemase (CPE) : what place for ceftazidime-avibactam in the belgian therapeutical arsenal ?\",\"authors\":\"S. Milas, M. Hites\",\"doi\":\"10.30637/2020.19-046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":341141,\"journal\":{\"name\":\"Revue Médicale de Bruxelles\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue Médicale de Bruxelles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30637/2020.19-046\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue Médicale de Bruxelles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30637/2020.19-046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment of infections due to Extended Spectrum b-Lactamase Producing Enterobacteriaceae (ESBL) and/or producing Carbapenemase (CPE) : what place for ceftazidime-avibactam in the belgian therapeutical arsenal ?